You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Kidney conditions
  5. Chronic kidney disease

Renal replacement therapy and conservative management

  • NICE guideline
  • Reference number: NG107
  • Published:  03 October 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Surveillance report

  • 2023 exceptional surveillance of renal replacement therapy and conservative management (NICE guideline NG107)

  • Other supporting evidence

  • Methods (PDF 1.21 MB)

    Published:
    03 October 2018
  • Evidence review

  • Evidence reviews – October 2018

  • A: Initiating RRT (PDF 1.52 MB)

    Published:
    03 October 2018
  • B: Modalities of RRT (PDF 6.62 MB)

    Published:
    03 October 2018
  • C: Sequencing modalities of RRT (PDF 1.45 MB)

    Published:
    03 October 2018
  • D: When to create access formation and/or list for transplantation (PDF 1.94 MB)

    Published:
    03 October 2018
  • E: When to assess for RRT (PDF 1.41 MB)

    Published:
    03 October 2018
  • F: How to assess people for RRT (PDF 1.32 MB)

    Published:
    03 October 2018
  • G: Indicators for transferring/discontinuing RRT (PDF 1.19 MB)

    Published:
    03 October 2018
  • H: Symptom recognition (PDF 3.51 MB)

    Published:
    03 October 2018
  • I: Dietary management and fluid restriction (PDF 1.56 MB)

    Published:
    03 October 2018
  • J: Frequency of review (PDF 1.05 MB)

    Published:
    03 October 2018
  • K: Information, education and support (PDF 2.42 MB)

    Published:
    03 October 2018
  • L: Decision support interventions (PDF 1.44 MB)

    Published:
    03 October 2018
  • M: Coordinating care (PDF 1.42 MB)

    Published:
    03 October 2018
  • Economic analysis

  • Cost-effectiveness analysis: HDF versus high-flux HD (report) (PDF 2.06 MB)

    Published:
    03 October 2018
Back to top